Clinical Trial Detail

NCT ID NCT01642251
Title Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer or Metastatic Large Cell Neuroendocrine Non-small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

small cell carcinoma

lung non-small cell carcinoma

lung small cell carcinoma

Therapies

Cisplatin + Etoposide

Veliparib

Age Groups: adult

No variant requirements are available.